Meeting
2022 ASCO Annual Meeting
DOLAF: An international multicenter phase II trial of durvalumab (MEDI4736) plus olaparib plus fulvestrant in patients with metastatic or locally advanced ER-positive, HER2-negative breast cancer selected using criteria that predict sensitivity to olaparib.
Authors
Severine Guiu Lahaye
Institut de Cancerologie de Montpellier, Montpellier, France
Severine Guiu Lahaye , Judith Balmana Gelpi , Ludovic Gauthier , Frédéric Bigot , Anthony Goncalves , Jean-Sebastien Frenel , Thomas Bachelot , Florence Dalenc , Audrey Mailliez , Camille Chakiba , Dominique Genet , Nathalie Dohollou , Isabelle Desmoulins , Jean-Luc Re Canon , Clara Guyonneau , Adrien Buisson , Louise-Marie Chevalier , Suzette Delaloge , Philippe Follana
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Hormone Receptor-Positive
Clinical Trial Registration Number
NCT04053322
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS1116)
DOI
10.1200/JCO.2022.40.16_suppl.TPS1116
Abstract #
TPS1116
Poster Bd #
488b
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2022 ASCO Genitourinary Cancers Symposium
ORCHID: A phase II study of olaparib in metastatic renal cell carcinoma patients harboring a BAP1 or other DNA repair gene mutations.
First Author: Yasser Ged
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan